Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0.515. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: U54 CA 272688 , U01 CA233056
Deutsche Krebshilfe
Grant: 70113455
National Institutes of Health
Grant: 1U54CA272688-01
CAP-IT Center for LNP RNA Immunoprevention
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL157174-04
Systematic identification of minor histocompatibility antigens to address GVHD
National Institutes of Health
Grant: 5U01CA233056-04
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
NCI NIH HHS
Grant: HHSN261201500039C
NHLBI NIH HHS
Grant: R01 HL157174
NCI NIH HHS
Grant: U01 CA233056
NCI NIH HHS
Grant: U54 CA272688
FWCI
5.59
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords